Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Zuo

Showing results (231-240 of 281) with videos related to

Pageof 29
Sort By:
ACR Open Rheumatology|December 3, 2022
Predictors and Interrelationship of Patient-Reported Outcomes in Antiphospholipid Syndrome: A Cross-Sectional StudyJulia K Weiner, Tristin Smith, Claire K Hoy, et al.
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2025
Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole-blood RNA transcriptomeAmala Ambati, Feiyang Ma, Katarina Kmetova, et al.
JAMA Cardiology|May 7, 2025
Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular DiseaseYu Zuo, Somanathapura K NaveenKumar, Sherwin Navaz, et al.
Asia-Pacific Journal of Public Health|October 30, 2014
Psychometric properties of the coronary heart disease scale of the quality-of-life instruments for chronic diseases (QLICD-CHD): an application to Cantonese patientsAn Fan, Shou Qiang Zhong, Xiao Yu Zuo, et al.
Nature Communications|August 4, 2025
Histone lactylation regulates DOCK4 to control heat nociception and supports Dynein-mediated Nav1.7 traffickingMan-Xiu Xie, Ren-Chun Lai, Yi-Bin Xiao, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
Endothelial cell-activating antibodies in COVID-19Hui Shi, Yu Zuo, Sherwin Navaz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2025
Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid SyndromeBruna de Moraes Mazetto Fonseca, Somanathapura K NaveenKumar, Srilakshmi Yalavarthi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2022
Endothelial Cell-Activating Antibodies in COVID-19Hui Shi, Yu Zuo, Sherwin Navaz, et al.
Pageof 29

Showing results (231-240 of 281) with videos related to

Sort By:
Pageof 29
ACR Open Rheumatology|December 3, 2022
Predictors and Interrelationship of Patient-Reported Outcomes in Antiphospholipid Syndrome: A Cross-Sectional StudyJulia K Weiner, Tristin Smith, Claire K Hoy, et al.
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2025
Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole-blood RNA transcriptomeAmala Ambati, Feiyang Ma, Katarina Kmetova, et al.
JAMA Cardiology|May 7, 2025
Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular DiseaseYu Zuo, Somanathapura K NaveenKumar, Sherwin Navaz, et al.
Asia-Pacific Journal of Public Health|October 30, 2014
Psychometric properties of the coronary heart disease scale of the quality-of-life instruments for chronic diseases (QLICD-CHD): an application to Cantonese patientsAn Fan, Shou Qiang Zhong, Xiao Yu Zuo, et al.
Nature Communications|August 4, 2025
Histone lactylation regulates DOCK4 to control heat nociception and supports Dynein-mediated Nav1.7 traffickingMan-Xiu Xie, Ren-Chun Lai, Yi-Bin Xiao, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
Endothelial cell-activating antibodies in COVID-19Hui Shi, Yu Zuo, Sherwin Navaz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2025
Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid SyndromeBruna de Moraes Mazetto Fonseca, Somanathapura K NaveenKumar, Srilakshmi Yalavarthi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 17, 2022
Endothelial Cell-Activating Antibodies in COVID-19Hui Shi, Yu Zuo, Sherwin Navaz, et al.
Pageof 29